biospecimen__admin__batch_number	314.59.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	2FECC1E9-D75D-4E7A-8F82-176E1DC52C78
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-ED-A66X-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-ED-A66X-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-ED-A66X-01A
biospecimen__bio__biospecimen_barcode_bottom	0153878208
biospecimen__bio__day_of_creation	24
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	06
biospecimen__bio__pathology_report_file_name	TCGA-ED-A66X.F83A9A75-387A-4A66-9817-084A8E633E37.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A310
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.00
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-ED-A66X
biospecimen__shared__patient_id	A66X
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	1A71F43F-2DF2-4D1F-AAAC-EF8DE5B5857E
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.7
clinical__chol_lihc_shared__albumin_result_upper_limit	5.1
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	9
clinical__chol_lihc_shared__creatinine_lower_level	4.1
clinical__chol_lihc_shared__creatinine_upper_limit	5.6
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	4.5
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	20
clinical__chol_lihc_shared__fetoprotein_outcome_value	5840
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.3
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	35
clinical__clin_shared__bcr_followup_barcode	TCGA-ED-A66X-F56838
clinical__clin_shared__bcr_followup_uuid	40296676-2917-4796-96F2-2EEF075840B5
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	268
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__days_to_new_tumor_event_after_initial_treatment	124
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	eddbcf68-9e56-4e1e-8596-7dea4ee10ecf
gdc__aliquots__concentration	0.15
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-ED-A66X-01A-11R-A310-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	2528303d-bf75-420e-b3d1-7ff9653c4d2c
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	338b8afe-b106-42aa-aa74-07f90e1430b4
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	b75ca9e4-a474-4960-9343-c8e9524cd096
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	93716951-1ffb-5a09-84c7-382353a619e7
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1978
gdc__diagnoses__age_at_diagnosis	12947
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-12947.0
gdc__diagnoses__days_to_last_follow_up	406.0
gdc__diagnoses__diagnosis_id	6c368a7d-ad92-59c4-a20b-5edb545b3b46
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	21.10726643598616
gdc__exposures__exposure_id	775d98fd-0cd6-5aeb-b247-e51d4e10697b
gdc__exposures__height	170.0
gdc__exposures__weight	61.0
gdc__file_id	e08956b0-a3fb-4591-aff1-113c41c4b4f1
gdc__file_name	359c393d-f522-462f-b476-d8f158566038.mirbase21.mirnas.quantification.txt
gdc__file_size	50387
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	50720ee507a96b226d1f327dea8b32f0
gdc__portions__is_ffpe	false
gdc__portions__portion_id	39a052e6-434b-4381-b3ed-962460a7c3e5
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	89
gdc__samples__initial_weight	2190.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	F83A9A75-387A-4A66-9817-084A8E633E37
gdc__samples__sample_id	c46cc628-1a71-4a9a-9111-8c78f89694f8
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	5.0
gdc__slides__percent_monocyte_infiltration	4.0
gdc__slides__percent_necrosis	7.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	58.0
gdc__slides__percent_tumor_cells	35.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	aa13614b-05d3-4ca6-89cf-df3d5c1e5c47
gdc__submitter_id	mirna_swap_dr11_236_MirnaExpression61163aaa-1fa0-4f69-8bfb-c5a7333d8aaa_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	ED
gdc__tissue_source_site__name	Asterand
gdc__tissue_source_site__tissue_source_site_id	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4
gdc__treatments__treatment_id	e5c646c9-fdf7-5762-8169-572d9d668330
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:52.897+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/eddbcf68-9e56-4e1e-8596-7dea4ee10ecf-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/eddbcf68-9e56-4e1e-8596-7dea4ee10ecf-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129758
manually_curated__local_md5	874d7837304200cdbf1cfe3bec21f88d
manually_curated__opengdc_download_date	2018-10-16T17:11:30.000656+02:00
manually_curated__opengdc_file_md5	bf33101fca2386694de2b368c07dad69
manually_curated__opengdc_file_size	50386
manually_curated__opengdc_id	eddbcf68-9e56-4e1e-8596-7dea4ee10ecf-meq
manually_curated__origin_file_size	129758
manually_curated__origin_last_modified_date	Tue Oct 16 17:15:00 CEST 2018
manually_curated__origin_md5	874d7837304200cdbf1cfe3bec21f88d
manually_curated__tissue_status	tumoral
